Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Augmentin 125/31 SF oral suspension (GlaxoSmithKline UK Ltd) |
| BNF code | 0501013K0BBAJAD |
| Virtual Medicinal Product | Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free |
| Name | Augmentin 125/31 SF oral suspension |
| Date of name applicability | 2 Sep 2005 |
| Previous name | Augmentin 125/31 SF suspension |
| Supplier | GlaxoSmithKline UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Oral |
| Actual Medicinal Product Packs | |
| Augmentin 125/31 SF oral suspension (GlaxoSmithKline UK Ltd) 100 ml | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.